J. Bourhis, C. Sire, Y. Tao, L. Martin, M. Alfonsi, et al.. Pembrolizumab versus cetuximab, concomitant with radiotherapy (RT) in locally advanced head and neck squamous cell carcinoma (LA-HNSCC): Results of the GORTEC 2015-01 ``PembroRad'' randomized trial.
Annals of Oncology, 2020, 31 (4), pp.S1168.
⟨10.1016/j.annonc.2020.08.2268⟩.
⟨hal-03600471⟩